中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2013年
4期
68
,共1页
宫颈癌%肿瘤标记物%癌胚抗原%糖抗原
宮頸癌%腫瘤標記物%癌胚抗原%糖抗原
궁경암%종류표기물%암배항원%당항원
Cervical cancer%Tumor marker%CEA%CA125
目的:探讨肿瘤标记物 CEA、CA125在宫颈癌中的检测的临床价值.方法:选取笔者所在医院2011年1月-2012年8月经临床确诊的100例宫颈癌患者(宫颈癌组)及40例进行健康体检的妇女(对照组)为研究对象,测定两组的血清肿瘤标记物癌胚抗原(CEA)、糖抗原(CA125).结果:宫颈癌组的血清 CEA、CA125含量显著高于对照组(P<0.05).在宫颈癌组中,随着临床分期的增加 CEA、CA125的阳性率逐渐增加,Ⅲ、Ⅳ期较Ⅰ、Ⅱ期显著增加(P<0.05).结论:肿瘤标记物 CEA、CA125在宫颈癌中有较高的诊断价值,可辅助判断宫颈癌的临床分期.
目的:探討腫瘤標記物 CEA、CA125在宮頸癌中的檢測的臨床價值.方法:選取筆者所在醫院2011年1月-2012年8月經臨床確診的100例宮頸癌患者(宮頸癌組)及40例進行健康體檢的婦女(對照組)為研究對象,測定兩組的血清腫瘤標記物癌胚抗原(CEA)、糖抗原(CA125).結果:宮頸癌組的血清 CEA、CA125含量顯著高于對照組(P<0.05).在宮頸癌組中,隨著臨床分期的增加 CEA、CA125的暘性率逐漸增加,Ⅲ、Ⅳ期較Ⅰ、Ⅱ期顯著增加(P<0.05).結論:腫瘤標記物 CEA、CA125在宮頸癌中有較高的診斷價值,可輔助判斷宮頸癌的臨床分期.
목적:탐토종류표기물 CEA、CA125재궁경암중적검측적림상개치.방법:선취필자소재의원2011년1월-2012년8월경림상학진적100례궁경암환자(궁경암조)급40례진행건강체검적부녀(대조조)위연구대상,측정량조적혈청종류표기물암배항원(CEA)、당항원(CA125).결과:궁경암조적혈청 CEA、CA125함량현저고우대조조(P<0.05).재궁경암조중,수착림상분기적증가 CEA、CA125적양성솔축점증가,Ⅲ、Ⅳ기교Ⅰ、Ⅱ기현저증가(P<0.05).결론:종류표기물 CEA、CA125재궁경암중유교고적진단개치,가보조판단궁경암적림상분기.
Objective:To investigate the clinical value of tumor markers CEA,CA125 detection in cervical cancer and the significance.Methods:100 cases of cervical cancer (the cervical cancer group )that was clinical diagnosis from January 2011 to August 2012 in author’s hospital and 40 cases of healthy women (the control group) were chosen as the research object,two groups were measured in serum tumor marker carcinoembryonic antigen (CEA),carbohydrate antigens (CA125).Results:Serum CEA,CA125 in the cervical cancer group were significantly higher than those in the control group (P<0.05).In the cervical cancer group, CEA,CA125 positive rate increased gradually along with the clinical stagin,stage Ⅲ,Ⅳ were significantly than istage Ⅰ,Ⅱ (P<0.05).Conclusion:There is a high diagnostic value of the tumor markers CEA,CA125 in cervical carcinoma;they can help judge clinical cervical cancer staging.
